Early Conversations in Type 2 Diabetes: Insights from the first IntroDia^™ patient data

IntroDia^™ is the largest multinational survey of its kind to date investigating early conversations between physicians and Type 2 Diabetes patients. It is studying the impact these conversations can have on self-management and investigating current barriers to effective communication.

We interviewed two members of the IntroDia^™ Advisory Board, Dr Matthew Capehorn and Dr Bill Polonsky at the 75th Scientific Sessions of the American Diabetes Association in Boston, Massachusetts in June 2015 to learn more about the first patient insights of the IntroDia^™ Survey.